David Katz to Retrospective Studies
This is a "connection" page, showing publications David Katz has written about Retrospective Studies.
Connection Strength
0.370
-
Ben-Chetrit E, Bnaya A, Barchad OW, Vedder K, Katz DE. Chloramphenicol treatment revisited - demographics, clinical characteristics, and outcomes of hospitalized patients. Eur J Clin Microbiol Infect Dis. 2024 Aug; 43(8):1667-1671.
Score: 0.102
-
Mendlovic J, Gargir E, Katz DE. A fully automated inpatient transport system. Technol Health Care. 2021; 29(5):1049-1056.
Score: 0.080
-
Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Marchaim D. Diabetic foot infection in hospitalized adults. J Infect Chemother. 2016 Mar; 22(3):167-73.
Score: 0.057
-
Katz DE, Martone WJ. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin. Clin Ther. 2007 Nov; 29(11):2440-7.
Score: 0.032
-
Leibner G, Katz DE, Esayag Y, Kaufman N, Brammli-Greenberg S, Rose AJ. Incorporating clinical and demographic data into the Elixhauser Comorbidity Model: deriving and validating an enhanced model in a tertiary hospital's internal medicine department. BMC Health Serv Res. 2024 Dec 05; 24(1):1523.
Score: 0.026
-
Zilberman-Itskovich S, Strul N, Chedid K, Martin ET, Shorbaje A, Vitkon-Barkay I, Marcus G, Michaeli L, Broide M, Yekutiel M, Zohar Y, Razin H, Low A, Strulovici A, Israeli B, Geva G, Katz DE, Ben-Chetrit E, Dodin M, Dhar S, Parsons LM, Ramos-Mercado A, Kaye KS, Marchaim D. A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitals. Infect Control Hosp Epidemiol. 2021 09; 42(9):1082-1089.
Score: 0.020
-
Shpunt Y, Estrin I, Levi Y, Saadon H, Ben-Yossef G, Goldshtein L, Klafter D, Zilberman-Itskovich S, Ben-David D, Katz DE, Lazarovitch T, Zaidenstein R, Marchaim D. Antimicrobial use for asymptomatic bacteriuria-First, do no harm. Infect Control Hosp Epidemiol. 2021 01; 42(1):37-42.
Score: 0.020
-
Kronenfeld N, Zilberman-Itskovich S, Lazarovitch T, Zaidenstein R, Saadon H, Maya T, Katz DE, Marchaim D. The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital. J Glob Antimicrob Resist. 2020 09; 22:5-8.
Score: 0.019
-
Tal-Jasper R, Katz DE, Amrami N, Ravid D, Avivi D, Zaidenstein R, Lazarovitch T, Dadon M, Kaye KS, Marchaim D. Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections. Antimicrob Agents Chemother. 2016 05; 60(5):3127-31.
Score: 0.014